Patents by Inventor Maria Kristina Andersson

Maria Kristina Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of CYP2C19 polymorphisms
    Publication number: 20030059774
    Abstract: The invention provides methods, PCR primers, sequence determination oligonucleotides, isolated polynucleotides, and kits for determining a human's capacity to metabolize a substrate of the CYP2C19 enzyme using genetic analysis.
    Type: Application
    Filed: August 30, 2001
    Publication date: March 27, 2003
    Inventors: Carl Risinger, Maria Kristina Andersson, Tommy Lewander, Erik Olaisson
  • Detection of CYP2D6 polymorphisms
    Publication number: 20030044797
    Abstract: The invention provides methods, PCR primers, sequence determination oligonucleotides, and kits for predicting a human's capacity to metabolize a substrate of the CYP2D6 enzyme using genetic analysis.
    Type: Application
    Filed: August 29, 2001
    Publication date: March 6, 2003
    Inventors: Carl Risinger, Maria Kristina Andersson, Tommy Lewander, Erik Olaisson
  • Reagents and methods for detection of heart failure
    Patent number: 6528268
    Abstract: The invention provides novel reagents, kits, and methods for diagnosis of predisposition to left ventricular heart failure, based on analysis of polymorphic variants of the genomic nucleic acid set forth in SEQ ID NO:1
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: March 4, 2003
    Assignee: Sequenom-Gemini Limted
    Inventors: Maria Kristina Andersson, Lars Gunnar Ture Berglund, Rikard Henry Reneland, Gail Isabel Reid Adam
  • Detection of CYP3A4 and CYP2C9 polymorphisms
    Publication number: 20030017469
    Abstract: The invention provides oligonucleotide primer pairs, sequence determination oligonucleotides, and kits for amplification and detection of novel single nucleotide polymorphisms in the 5′ flanking regions of the CYP3A4 and CYP2C9 genes.
    Type: Application
    Filed: August 30, 2001
    Publication date: January 23, 2003
    Inventors: Carl Risinger, Maria Kristina Andersson, Tommy Lewander, Erik Olaisson
  • Methods for assessing cardiovascular status and compositions for use thereof
    Patent number: 6197505
    Abstract: The present invention provides methods for assessing cardiovascular status in an individual, which comprise determining the sequence at one or more polymorphic positions within the human genes encoding angiotensin converting enzyme (ACE), angiotensinogen (AGT), and/or type 1 angiotensin II receptor (AT1). The invention also provides isolated nucleic acids encoding ACE, AGT, and AT1 polymorphisms, nucleic acid probes that hybridize to polymorphic positions, kits for the prediction of cardiovascular status, and nucleic acid and peptide targets for use in identifying candidate cardiovascular drugs.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: March 6, 2001
    Assignee: Pyrosequencing AB
    Inventors: Leif Torbjörn Norberg, Maria Kristina Andersson, Per Harry Rutger Lindström